Posttranscriptional Regulation of Urokinase Receptor mRNA: Identification of a Novel Urokinase Receptor mRNA Binding Protein in Human Mesothelioma Cells

REFERENCES

• Angel, P., M. Imagawa, R. Chui, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729–739.
   PubMed Web of Science ®Google Scholar
• Antalis, T. M., and D. Godbolt. 1991. Isolation of intact nuclei from hematopoietic cell types. Nucleic Acid Res. 19:4301.
   PubMedGoogle Scholar
• Atwater, J. A., R. Wisdom, and I. M. Verma. 1990. Regulated mRNA stability Annu. Rev. Genet. 24:519–541.
   PubMed Web of Science ®Google Scholar
• Bernstein, P. L., D. J. Herrick, R. D. Prokipeak, and J. Ross. 1992. Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant. Genes Dev. 6:642–654.
   PubMed Web of Science ®Google Scholar
• Brewer, G. 1991. An A+U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. Mol. Cell. Biol. 11:2460–2466.
   PubMed Web of Science ®Google Scholar
• Chen, F. Y., F. M. Amara, and J. A. Wright. 1993. Mammalian ribonucleotide reductase R1 mRNA stability under normal and phorbol ester stimulating conditions: involvement of a cis-trans interaction at the 3′ untranslated region. EMBO J. 12:3977–3986.
   PubMedGoogle Scholar
• Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299.
   PubMed Web of Science ®Google Scholar
• Cubellis, M. V., M. L. Nolli, G. Cassani, and F. Blasi. 1986. Binding of single-chain prourokinase to the urokinase receptors of human U937 cells. J. Biol. Chem. 261:15819–15822.
   PubMed Web of Science ®Google Scholar
• Dano, K., P. A. Andreasen, J. Grondahl-Hansen, P. Kristensen, L. S. Nielsen, and L. Skriver. 1985. Plasminogen activators, tissue degradation and cancer. Adv. Cancer Res. 44:139–266.
   PubMed Web of Science ®Google Scholar
• Hsu, S. M., P. L. Hus, X. Zhao, C. S. Kao-Shan, and J. Whang-Peng. 1988. Establishment of human mesothelioma cell lines (MS-1, -2) and production of a monoclonal antibody (anti-MS) with diagnostic and therapeutic potential. Cancer Res. 48:5228–5236.
   PubMedGoogle Scholar
• Idell, S., C. Zweib, A. Kumar, K. B. Koenig, and A. R. Johnson. 1992. Pathways of fibrin turnover of human mesothelial cells in vitro. Am. J. Respir. Cell. Mol. Biol. 7:414–426.
   PubMed Web of Science ®Google Scholar
• Kanamori, H., N. Suzuki, H. Siomi, T. Nosaka, A. Sato, H. Sabe, M. Hatanaka, and T. Honjo. 1990. HTLV-1 P21 rex stabilizes human interleukin receptor a chain mRNA. EMBO J. 9:4161–4166.
   PubMed Web of Science ®Google Scholar
• Lee, W. M. F., F. C. Lin, and T. Curran. 1988. Activation of the transforming potential of the human fos proto-oncogene requires message stabilizationand results in increased amounts of partially modified Fos protein. Mol. Cell. Biol. 8:5521–5527.
   PubMedGoogle Scholar
• Leibold, E. A., and S. N. Munro. 1988. Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5′ untranslated region of ferritin heavy and light-subunit mRNAs. Proc. Natl. Acad. Sci. USA 85:2171–2175.
   PubMed Web of Science ®Google Scholar
• Liang, H., and J. P. Jost. 1991. An estrogen-dependent polysomal protein binds to the 5′ untranslated region of the chicken vitellogenin mRNA. Nucleic Acids Res. 19:2289–2294.
   PubMedGoogle Scholar
• Lund, L. R., E. Ronne, A. L. Roldan, N. Behrendt, J. Romer, F. Blasi, and K. Dano. 1991. Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human mono-cyte-like U937 cells. J. Biol. Chem. 266:5177–5181.
   PubMedGoogle Scholar
• Lund, L. R., V. Ellis, E. Ronne, C. Pyke, and K. Dano. 1995. Transcriptional and post-transcriptional regulation of receptor for urokinase-type plasminogen activator by cytokines and tumor promoters in the human lung carcinoma cell line A549. Biochem. J. 310:345–452.
   PubMed Web of Science ®Google Scholar
• Makela, T. P., R. Alitalo, Y. Paulsson, B. Westermark, C.-H. Heldin, and K. Alitalo. 1987. Regulation of platelet-derived growth factor gene expression by transforming growth factor β and phorbol ester in human leukemia cell lines. Mol. Cell. Biol. 7:3656–3662.
   PubMed Web of Science ®Google Scholar
• Malter, J. S., and Y. Hong. 1991. A redox switch and phosphorylation are involved in the posttranslational up-regulation of the adenosine-uridine binding factor by phorbol ester ionophore. J. Biol. Chem. 266:3167–3171.
   PubMed Web of Science ®Google Scholar
• Nielsen, L. S., G. M. Kelleman, N. Behrendt, R. Picone, K. Dano, and F. Blasi. 1988. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator: identification in human tumor cell lines and partial purification. J. Biol. Chem. 263:2358–2363.
   PubMed Web of Science ®Google Scholar
• Nishizuka, Y. 1986. Studies and perspective of protein kinase C. Science 233:305–312.
   PubMed Web of Science ®Google Scholar
• Pepper, M. S., K. Matsumoto, T. Nakamura, and R. Montesano. 1992. Hepatocyte growth factor increases urokinase-type plasminogen activator (uPA) and UPA receptor expression in Madin-Darby canine epithelial cells. J. Biol. Chem. 267:20493–20496.
   PubMed Web of Science ®Google Scholar
• Picone, R., E. L. Kajtaniak, L. S. Nielsen, N. Behrendt, M. R. Mastronicola, M. V. Cubellis, M. P. Stopelli, S. Pedersen, K. Dano, and F. Blasi. 1989. Regulation of urokinase receptors in monocyte-like U937 cells by phorbol myristate acetate. J. Cell Biol. 108:693–702.
   PubMed Web of Science ®Google Scholar
• Raymond, V., J. A. Atwater, and I. M. Verma. 1989. Removal of an mRNA destabilizing element correlates with the increased oncogenecity of proto-oncogene fos. Oncogene Res. 4:861–865.
   Google Scholar
• Roldan, A. L., M. Y. Cubellis, M. T. Masucci, N. L. Behrendt, L. R. Lund, K. Dano, E. Apella, and F. Blasi. 1990. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface plasmin dependent proteolysis. EMBO J. 9:467–474.
   PubMed Web of Science ®Google Scholar
• Sachs, A. B. 1993. Messenger RNA degradation in eukaryotes. Cell 74:413–421.
   PubMed Web of Science ®Google Scholar
• Shaw, G., and R. Kanmen. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659–667.
   PubMed Web of Science ®Google Scholar
• Shetty, S., A. Kumar, A. Johnson, S. Pueblitz, and S. Idell. 1995. Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mito-genesis and proteolysis. Am. J. Physiol. Lung Cell Mol. Physiol. 268:L972–L982.
   PubMedGoogle Scholar
• Shyu, A. B., M. E. Greenberg, and J. G. Belasco. 1989. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev. 5:221–231.
   Google Scholar
• Shyu, A. B., J. G. Belasco, and M. E. Greenberg. 1990. Two distinct destabilizing elements in the c-fos message trigger deadenylation as a first step in rapid mRNA decay. Genes Dev. 5:221–231.
   Google Scholar
• Stacey, K. J., Y. Nagamine, and D. A. Hume. 1994. RNA synthesis inhibition stabilizes urokinase in RNA in macrophages. FEBS Lett. 356:311–313.
   PubMedGoogle Scholar
• Stoppelli, M. P., C. Tacchettti, M. V. Cubellis, A. Corti, V. J. Hearing, G. Cassani, E. Appella, and F. Blasi. 1986. Autocrine saturation of pro-uroki-nase receptors on human A431 cells. Cell 45:675–684.
   PubMed Web of Science ®Google Scholar
• Wisdom, R., and W. Lee. 1991. The protein coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. Genes Dev. 5:232–243.
   PubMed Web of Science ®Google Scholar
• Yen, T. J., P. S. Machlin, and D. W. Cleveland. 1988. Autoregulated instability of p-tubulin mRNAs by recognition of the nascent amino terminus of P-tubulin. Nature (London) 334:580–584.
   PubMed Web of Science ®Google Scholar